These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 24118786

  • 1. Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats.
    Marichal-Cancino BA, Altamirano-Espinoza AH, Manrique-Maldonado G, MaassenVanDenBrink A, Villalón CM.
    Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):240-7. PubMed ID: 24118786
    [Abstract] [Full Text] [Related]

  • 2. Analysis of anandamide- and lysophosphatidylinositol-induced inhibition of the vasopressor responses produced by sympathetic stimulation or noradrenaline in pithed rats.
    Marichal-Cancino BA, Manrique-Maldonado G, Altamirano-Espinoza AH, Ruiz-Salinas I, González-Hernández A, Maassenvandenbrink A, Villalón CM.
    Eur J Pharmacol; 2013 Dec 05; 721(1-3):168-77. PubMed ID: 24076186
    [Abstract] [Full Text] [Related]

  • 3. Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α2-adrenoceptors and 5-HT1 receptors.
    González-Hernández A, Lozano-Cuenca J, Marichal-Cancino BA, MaassenVanDenBrink A, Villalón CM.
    J Headache Pain; 2018 May 25; 19(1):40. PubMed ID: 29802544
    [Abstract] [Full Text] [Related]

  • 4. The role of pre-junctional D2 -like receptors mediating quinpirole-induced inhibition of the vasodepressor sensory CGRPergic out-flow in pithed rats.
    Manrique-Maldonado G, González-Hernández A, Altamirano-Espinoza AH, Marichal-Cancino BA, Ruiz-Salinas I, Villalón CM.
    Basic Clin Pharmacol Toxicol; 2014 Feb 25; 114(2):174-80. PubMed ID: 23964609
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats.
    Rubio-Beltrán E, Labastida-Ramírez A, Hernández-Abreu O, MaassenVanDenBrink A, Villalón CM.
    Eur J Pharmacol; 2017 Oct 05; 812():97-103. PubMed ID: 28694067
    [Abstract] [Full Text] [Related]

  • 6. The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.
    González-Hernández A, Manrique-Maldonado G, Lozano-Cuenca J, Muñoz-Islas E, Centurión D, Maassen VanDenBrink A, Villalón CM.
    Eur J Pharmacol; 2011 Jun 01; 659(2-3):233-43. PubMed ID: 21473863
    [Abstract] [Full Text] [Related]

  • 7. Activation of 5-HT1B receptors inhibits the vasodepressor sensory CGRPergic outflow in pithed rats.
    González-Hernández A, Muñoz-Islas E, Lozano-Cuenca J, Ramírez-Rosas MB, Sánchez-López A, Centurión D, Ramírez-San Juan E, Villalón CM.
    Eur J Pharmacol; 2010 Jul 10; 637(1-3):131-7. PubMed ID: 20385119
    [Abstract] [Full Text] [Related]

  • 8. Potential Mechanisms Involved in Palmitoylethanolamide-Induced Vasodepressor Effects in Rats.
    Marichal-Cancino BA, González-Hernández A, MaassenVanDenBrink A, Ramírez-San Juan E, Villalón CM.
    J Vasc Res; 2020 Jul 10; 57(3):152-163. PubMed ID: 32248195
    [Abstract] [Full Text] [Related]

  • 9. Endovanilloids are potential activators of the trigeminovascular nocisensor complex.
    Dux M, Deák É, Tassi N, Sántha P, Jancsó G.
    J Headache Pain; 2016 Jul 10; 17():53. PubMed ID: 27189587
    [Abstract] [Full Text] [Related]

  • 10. Role of 5-HT7 receptors in the inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats.
    Cuesta C, García-Pedraza JÁ, García M, Villalón CM, Morán A.
    Vascul Pharmacol; 2014 Oct 10; 63(1):4-12. PubMed ID: 25179247
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological evidence that histamine H3 receptors inhibit the vasodepressor responses by selective stimulation of the rat perivascular sensory CGRPergic outflow.
    Manrique-Maldonado G, Altamirano-Espinoza AH, Marichal-Cancino BA, Rivera-Mancilla E, Avilés-Rosas V, Villalón CM.
    Eur J Pharmacol; 2015 May 05; 754():25-31. PubMed ID: 25704614
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E, Martín MI, López-Miranda V.
    Br J Pharmacol; 2007 Nov 05; 152(5):699-708. PubMed ID: 17704831
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
    Engel MA, Izydorczyk I, Mueller-Tribbensee SM, Becker C, Neurath MF, Reeh PW.
    Neuropeptides; 2011 Jun 05; 45(3):229-37. PubMed ID: 21514666
    [Abstract] [Full Text] [Related]

  • 14. Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats.
    Avilés-Rosas VH, Rivera-Mancilla E, Marichal-Cancino BA, Manrique-Maldonado G, Altamirano-Espinoza AH, Maassen Van Den Brink A, Villalón CM.
    Br J Pharmacol; 2017 Jul 05; 174(13):2001-2014. PubMed ID: 28369749
    [Abstract] [Full Text] [Related]

  • 15. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
    Romero TR, Pacheco Dda F, Duarte ID.
    Life Sci; 2013 May 02; 92(14-16):815-20. PubMed ID: 23123446
    [Abstract] [Full Text] [Related]

  • 16. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Romero TR, Resende LC, Guzzo LS, Duarte ID.
    Anesth Analg; 2013 Feb 02; 116(2):463-72. PubMed ID: 23302980
    [Abstract] [Full Text] [Related]

  • 17. Effect of some acute and prophylactic antimigraine drugs on the vasodepressor sensory CGRPergic outflow in pithed rats.
    Lozano-Cuenca J, González-Hernández A, Muñoz-Islas E, Sánchez-López A, Centurión D, Cobos-Puc LE, Villalón CM.
    Life Sci; 2009 Jan 30; 84(5-6):125-31. PubMed ID: 19041880
    [Abstract] [Full Text] [Related]

  • 18. Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.
    Moezi L, Gaskari SA, Liu H, Baik SK, Dehpour AR, Lee SS.
    Br J Pharmacol; 2006 Dec 30; 149(7):898-908. PubMed ID: 17043671
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.